Nature Biotechnology
Volume 40 Issue 5, May 2022
https://www.nature.com/nbt/volumes/40/issues/5

Editorial | 09 May 2022
Gene therapy at the crossroads
Two upcoming regulatory decisions represent a tipping point for commercial gene therapy, with implications for work on existing viral vectors and the pursuit of new ones.